@所有购药人！今起不扫码医保不结算，还有哪些影响？

Core Viewpoint - The implementation of the drug "QR code settlement" system nationwide marks a significant shift in drug regulation and consumer protection in the pharmaceutical industry, enhancing traceability and accountability in drug sales and distribution [1][3][6]. Group 1: Implementation and Impact - As of July 1, 2025, all pharmacies and medical institutions must scan drug traceability codes for insurance reimbursement, with non-compliance leading to inability to process payments [1][3]. - The National Medical Insurance Administration has collected 41.828 billion traceability code records, covering over 99% of medical institutions, with approximately 5 million consumers checking drug authenticity daily [3][4]. - The transition period until the end of 2025 allows for the management of existing non-coded drugs, but by January 1, 2026, all institutions must fully implement traceability code collection [4][6]. Group 2: Consumer Protection and Awareness - The traceability code serves as an "electronic ID" for each drug, ensuring that each code is unique and can only be scanned once for sale, helping to identify counterfeit or returned drugs [3][4]. - Consumers are encouraged to verify the traceability codes and avoid purchasing drugs without them, enhancing their role in monitoring drug safety [4][5]. Group 3: Industry Challenges and Costs - The new regulations may lead to short-term cost increases for pharmaceutical companies and pharmacies due to the need for system upgrades and compliance with new operational processes [5][7]. - Pharmacies and medical institutions must invest in technology to ensure compliance with the traceability code requirements, which may disproportionately affect smaller entities [7][8]. Group 4: Long-term Benefits - The traceability system is expected to combat the issue of "returned drugs," thereby protecting market order and enhancing brand reputation for pharmaceutical companies [8]. - In the long run, the traceability code system is anticipated to improve the overall health and sustainability of the pharmaceutical industry by ensuring quality and safety in drug distribution [8].